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Abstract. We have recently shown that discrete foci
are present in the nuclei of mammalian cells in which
each of the Ul, U2, U4/U6, and U5 snRNPs involved
in pre-mRNA splicing, and the non-snRNP-splicing
factor U2AF, are concentrated (Carmo-Fonseca, M.,
D. Tollervey, R. Pepperkok, S. Barabino, A . Merdes,
C. Brunner, P. D. Zamore, M . R. Green, E. Hurt,
and A . I . Lamond . 1991 . EMBO (Eur. Mol. Biol. Or-
gan.) J. 10:195-206; Carmo-Fonseca, M ., R. Pepper-
kok, B. S. Sproat, W. Ansorge, M . S. Swanson, and
A. I. Lamond. 1991. EMBO (Eur. Mol. Biol. Organ.)
J. 10:1863-1873) . Here, we identify these snRNP-rich
organelles as coiled bodies. snRNPs no longer concen-
trate in coiled bodies after cells are treated with the
transcription inhibitors a-amanitin or actinomycin D.
snRNP association with coiled bodies is also disrupted
by heat shock. This indicates that the association of
T
HE development of in vitro splicing extracts from
mammalian and yeast systems has resulted in major
advances in understanding the basic mechanism of
pre-mRNA splicing (for reviews see references 9, 27, 38,
41, 54). The splicing reaction involves two sequential trans-
esterification reactions, similar to that seen with group II
self-splicing introns (reviewed in reference 31) . Unlike self-
splicing introns however, nuclear pre-mRNA splicing re-
quires a complex set of trans-acting splicing factors which
bind to substrate RNAs in an ordered pathway to form an ac-
tive splicing complex or "spliceosome" (8, 17, 22, 26, 32, and
47) . Major components ofspliceosomes are the Ul, U2, U4/
U6, and U5 snRNPs, all ofwhich are required forboth splice-
osome assembly and splicing. In addition to these snRNNs,
recent studies have identified a number of non-snRNP pro-
tein factors which are also required for splicing in vitro (4,
23, 25, 33, 34, 55, 69, 74, 75).
In contrast with the substantial progress in dissecting the
splicing machinery in vitro, comparatively little is known
about how the splicing factors are organized in vivo, or how
splicing is integrated in the nucleus with transcription or
RNA processing reactions such as 3' polyadenylation. Many
previous studies have shown by indirect immunofluorescence
that autoimmune and monoclonal antibodies specific for
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snRNPs with coiled bodies may be connected with the
metabolism of nascent transcripts. A novel labeling
method is described which shows both the RNA and
protein components of individual snRNPs colocalizing
in situ. Using this procedure all spliceosomal snRNPs
are seen distributed in a nonhomogeneous pattern
throughout the nucleoplasm, excluding nucleoli. They
are most concentrated in coiled bodies, but in addition
are present in "speckled" structures which are distinct
from coiled bodies and which contain the non-snRNP
splicing factor SC-35. Ul snRNP shows a more wide-
spread nucleoplasmic staining, outside of coiled bodies
and "speckled" structures, relative to the other snRNPs.
The association of snRNPs with "speckles"' is dis-
rupted by heat shock but enhanced when cells are
treated with a-amanitin .
snRNP proteins, or for the snRNA-specific 2,2,7 trimethyl
guanosine cap structure (m3G-Cap), I stain the nucleoplasm
of mammalian cells in a characteristic pattern which is often
described as "speckled" or "punctate" (20, 28, 44, 45, 52, 58,
59, 60, 70). A mAb specific for a non-snRNP splicing factor
(SC-35), was shown to label a similar pattern of 20-50
"speckled" nuclear structures (23). In contrast, an anti-
peptide antibody raised against a different non-snRNP splic-
ing factor (U2AF), showed widespread nucleoplasmic label-
ing, rather than "speckles, and also stained a small number
of discrete, snRNP-containing foci (15, 75) . Antibodies
against hnRNP proteins also stain throughout the nucleo-
plasm, excluding nucleoli, without obvious accumulation in
either "speckles" or foci (18, 48) .
Recent studies on amphibian oocytes reveal a different pat-
tern of snRNP labeling (reviewed in reference 24) . Antibod-
ies specific for snRNP proteins and m3G-Cap structures
stain loops on lampbrush chromosomes and at least three
classes of extrachromosomal granules, termed A, B, and C
"snurposomes." A snurposomes contain only Ul snRNP
while B snurposomes contain all the spliceosomal snRNNs,
1. Abbreviation used in this paper: m3G-Cap, trimethyl guanosine cap.in approximately stoichiometric amounts, as determined by
in situ hybridization with 3H-labeled probes. B snurpo-
somes and lampbrush chromosome loops also label strongly
with the anti-SC-35 mAb (72). C snurposomes vary con-
siderably in size, but can be as large as 20 /,m and usually
have several B snurposomes on their surface. The large C
snurposomes have previously been described as "sphere or-
ganelles" (14). The relationship between snRNP-containing
structures in the nuclei of mammalian cells and the snurpo-
somes in amphibian oocytes is at present unclear.
Most previous studies on snRNP localization in mam-
malian cellshave been based largely or exclusively on the use
of antibodies specific for either common snRNP proteins
(Sm class) or the m3G-Cap structure which is common to
the U class of snRNAs, with the exception of U6 (reviewed
in 41 and 76) . These probes are valuable for identifying sites
where snRNPs are present in situ, but do not distinguish
which species of snRNPs are present at any particular site.
As the individual snRNPs involved in splicing bind to pre-
mRNAs in a stepwise pathway during spliceosome formation
in vitro, it is important to determine whether this is reflected
by any differences in their nuclear localization in vivo. This
requires probes which can specifically label each individual
snRNP species. We have recently addressed these questions
by using antisense oligonucleotide probes specific for in-
dividual snRNAs (15, 16). These antisense probes are made
of 2'-o-alkyl RNA and have been shown to bind highly
specifically to targeted snRNAs in vitro (5, 6, 10, 36, and
37) . This approach also affords the possibility ofestablishing
that fully assembled snRNPs are being detected, by double
labeling with antisense probes and antibodies specific for
snRNP proteins.
Our previous studies using the antisense probes showed
that U2, U4, U5, and U6 snRNAs were strongly labeled in
discrete nucleoplasmic foci, while Ul snRNA, in addition to
being in the foci, was widely distributed throughout the
nucleoplasm, excluding nucleoli. An antibody specific for
the splicing factor U2AF showed a similar nucleoplasmic
staining to Ul snRNP and also concentrated in the same foci
(15, 75). By microinjecting 2'-o-alkyl probes coupled to
fluorochromes into the nuclei of unfixed, living cells it was
also possible to demonstrate a similar pattern of snRNP
labeling in vivo (16).
In this study we extend our analysis of the snRNP-rich
nuclear foci and show that they are distinct from other
nucleoplasmic structures which form the overall "speckled
pattern" in cells stained with snRNP-specific antibodies. In
particular, we identify the foci as being coiled bodies and
present evidence that the association of snRNPs with foci is
linked to nuclear pre-mRNA metabolism.
Materials and Methods
Oligonucleotide Synthesis andLabeling
Oligonucleotides were synthesized as described by Sproat et al. (63). All
oligonucleotides were made of either 2'-o-methyl (63) or 2'-o-allyl RNA
(30) as indicated in the legend to Table I. Sequences of the oligonucleotides
are listed in TableI. Biotinylationof antisense probes was performed during
the solid phase synthesis as previously described (46).
Cell Culture
HeLa cells were grown on glass coverslips in MEM supplemented with 1%
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Table I. Sequence ofOligonucleotides
Catalogue
Oligonucleotide
￿
number
￿
Sequence (5'-3)
anti-U1 8 CCUICCAHUAAIUAU
anti-U2 516 IAACAIAUACUACACUU
anti-U3 543 UUUCHUICUC
anti-U4 112 CUGCCACUGCGCAAAGCU
anti-U5 194 UA*GUA*A*A*A*GGCG
anti-U6 191 A*UGGA*A*CGCUUCA*CGA*A*UUU
anti-28Sa 525 AIAICCAAUCCUUAU
anti-28Sb 523 IUCCIUIUUUCAAIA
Adlc 147 IACCAIAUIIACICIICC
All oligonucleotides were made of 2'-o-allyl RNA (30), except for reference
numbers 8, 112, and 147, which were 2'-o-methyl RNA. The catalogue number
refers to the laboratory catalogue identification number for each probe. The
oligonucleotides were either 5' or 3' end labeled with biotin (63). The bases
marked A* correspond to 2-aminoadenosine (36, 65, and 65). Other bases used
were uridine (U), adenosine (A), inosine (I), guanosine (G), and cytidine (C) .
glutamine, 10% FCS, and antibiotics (Gibco BRL, Grand Island, NY).
Cells were used after reaching a confluency of 50-80% .
For drug treatment cells on coverslips were placed in fresh medium con-
taining either 5 kg/ml actinomycin D (SigmaChemical Co., St. Louis, MO)
or 50 kg/nil a-amanitin (Sigma Chemical Co.). Microinjection of a-aman-
itin was performed using the AIS microinjection system previously de-
scribed (2, 3).
Forheat shockexperiments the coverslips weretransferredtoPetri dishes
or flasks containing pre-warmed (45°C) medium supplemented with 10 mM
Hepes, pH 7.4, and incubated in a 45 *C water bath for 15 min. Control cells
were also transferred to dishes and incubated for the same time in medium
kept at 37°C.
In Situ HybridizationandImmunofluorescence
Cells on coverslips were washed twice with PBS and processed according
to either ofthe following protocols: (a) cells were extracted with 0.5% Tri-
ton X-100 in CSK buffer for 30 s on ice and fixedin 3.7% paraformaldehyde
in the same buffer for 10 min at room temperature (15); or (b) cells were
fixed with 3.7% paraformaldehyde in CSKbuffer for 10 min, washed in PBS
(3 x 5 thin), and subsequently extracted with 0.2% SDS (molecularbiology
grade, Sigma Chemical Co.) 20 mM Tris, pH 7.4, 30 mM NaCl, and 2.5
mM EDTA, for 15 min at room temperature, with gentle shaking. After ex-
tensive washing in PBSthe cells were hybridizedwith biotinylated antisense
2'-o-alkyl RNA probes (final concentration 1 pM/pl) in a humid chamber
for 1 h at room temperature, or overnight at 4°C, as previously described
(15). Hybridization sites were detected with FITC-conjugated extravidin
(Sigma Chemical Co.) diluted 1:500 in avidin buffer (15). Immunofluores-
cence staining was performed as previously described (15), except that
Tween 20 was frequently omitted from the PBS washes. Double labeling
with antisense and antibody probes was performed as previously described
(15). For double immunolabeling the cells were consecutively incubated
with one primary antibody, appropriate fluorochrome-conjugated second-
ary antibody, then the other primary antibody and fluorochrome conjugate.
Note that double labeling with the 3C5 monoclonal and the other mAbs
used (see below for list of other antibodies) was possible because 3C5 is
IgM and all others are IgG. Specificity of double labeling using monoclonal
3C5 (IgM) and other mAbs (IgGs) was controlled by reacting cells with ei-
ther primary antibody alone, followed by incubation with either anti-IgM
or anti-IgG conjugates.
The following antibodies were used: mAbs anti-70K protein (7), anti-B"
protein ("4G3") (28), anti-2,2,7-trimethylguanosine cap structures (11),
anti-SC-35 splicing factor (23), anti-hnRNP peptides Cl-C2 ("4F4") and L
("4Díí") (18,48), andmonoclonal "3C5" (68); p80 coilin-specific humanan-
tiserum "Sh" (1) and rabbit antibodies raised against a ß-galactosidase fusion
protein containing the COOH-terminal region of p80 coilin (1).
Preparations were examined in a fluorescence microscope (íM35; Carl
Zeiss, Oberkochen, Germany) using a 100x objective. Images were re-
corded using a Hamamatsu SITcamera with a DVS3000 system (Hama-
matsu Photonics, Japan). Confocal fluorescence microscopywas performed
using the EMBL modular confocal microscope as previously described (15).Results
In Situ Labeling ofsnRNPs
In our previous studies it was demonstrated for both Ul and
U3 snRNPs that the in situ staining patterns of antisense and
antibody probes colocalized (15) . However, with the same
Triton X-100 pre-extraction conditions used in these studies,
a mAb which recognizes the U2 snRNP-specific protein B"
labeled not only bright foci, but also additional nucleoplas-
mic structures not detected by the U2 antisense probe (Fig .
1, compare A and B) . As previously discussed, the failure
to detect perfect colocalization of antibody and antisense
probes for U2 snRNP could have been due either to the pres-
ence of free B" protein in the nucleus (i.e ., not assembled
with U2 snRNA), or to the presence of U2 snRNP in struc-
tures where the binding site for the antisense probe was not
accessible . To try to resolve this questionwe have systemati-
cally examined different in situ labeling procedures with the
aim ofuncovering specific labeling ofU2 snRNA in the addi-
tional structures stained by the anti-B" antibody.
Using a novel procedure, involving SDS extraction of
formaldehyde-fixed cells (see Materials and Methods), we
now observe colocalization of the labeling patterns of the
U2-specific antisense and antibody probes (Fig . 1, compare
C and D ; see also Fig . 3, B and E) . With both probes, the
foci are stained more brightly than any other nuclear struc-
ture, confirming that they are the most concentrated sites of
U2 snRNP accumulation (Fig . 1, arrows) . Both probes also
reveal U2 snRNP distributed throughout the nucleoplasm in
a non-homogeneous pattern . This pattern includes additional
concentrated staining regions giving the appearance of
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"speckles" (Fig . 1, arrowheads) . Having now obtained condi-
tions whereby antibody and antisense probes to U2 snRNP
co-localize, we next sought to carefully control whether this
SDS extraction method produced specific labeling ofU2 and
other RNA species (Figs . 2 and 3) .
Nine antisense probes complementary to different RNA
targets were tested (Fig . 2) . The Ul-specific probe (Fig . 2 A)
showed the same widespread nucleoplasmic distribution ob-
served previously (15, 16) . As with previous methods, the Ul
antisense probe colocalized with the staining pattern of a
mAb which recognizes the U1-specific 70K antigen (data not
shown) . The Ul staining pattern excludes nucleoli, but in-
cludes staining of foci and "speckles," together with consid-
erable additional nucleoplasmic labeling . In contrast, each
of the U2, U4, U5, and U6 snRNA-specific probes showed
a similar labeling pattern to each other (Fig . 2, B-E) . In
each case we observe bright staining in foci plus additional
nucleoplasmic labeling, excluding nucleoli . Within the nu-
cleoplasmic staining pattern each probe showed more con-
centrated labeling of "speckled" structures . As a negative
control, a probe not complementary to any RNA known to
be expressed inHeLa cells was tested and showed no specific
labeling of either nuclear or cytoplasmic structures (Fig . 2
F) . A probe for the nucleolar snRNA, U3, exclusively la-
beled nucleoli (Fig . 2 G) . Two probes specific for separate
regions of 28S rRNA both strongly labeled the cytoplasm
and nucleoli, as expected, but not the nucleoplasm (Fig . 2,
H and I) .
Competitive hybridization experiments were also per-
formed to examine the specificity of the different labeling
patterns obtained using theSDS method (Fig . 3) . Each of the
Ul, U2, and U3 snRNA probes was hybridized in situ to-
3
Figure 1 . In situ labeling of
U2snRNP HeLa cells were
extracted with Triton X-100
(A and B) or SDS (C and D) .
On Triton-extracted cells the
U2 antisense probe labels ex-
clusively foci (A) . Double la-
beling with a U2-specific mAb
(anti-B") reveals the foci (ar-
rows) and additional nucleo-
plasmic staining (arrowheads)
(B) . After SDS extraction
both antisense (C) and anti-
body (D) probes colocalize
and label foci (arrows) and nu-
cleoplasmic speckled structures
(arrowheads) . Bar, 10 pm .Figure 2. In situ hybridization on SDS-extracted cells . HeLa cells were incubated with antisense probes complementary to Ul (A), U2
(B), U4 (C), U5 (D), and U6 (E) snRNAs ; the first intron of the adenovirus major late transcript (F) ; U3 snRNA (G), and 28S rRNA
(H and I) . Bar, 10 ,am .
gether with a large excess of nonbiotinylated probe com-
plementary to a different snRNA species (Fig . 3, A-C) . In
each case, the antisense labeling pattern was not competed
by the non-cognate competitor. Parallel double-labeling with
the U2-specific anti-B" antibody also demonstrated that only
the U2 antisense probe colocalized (Fig . 3, compare B and
E with A andD and C and F) . When the antisense probes
were hybridized together with a large excess of nonbi-
otinylated probe of identical sequence however nuclear
staining was lost in each case (Fig . 3, G-I) . As an internal
control, double labeling was again performed with the anti-
B" antibody and shown to be unaffected (Fig . 3, J-L) .
The fact that antisense probes specific for U3 orrRNA la-
bel only nucleoli, or nucleoli and cytoplasm, but not
nucleoplasmic structures, while probes for each of the
snRNAsknown to be required forpre-mRNA splicing exclu-
sively label the nucleoplasm, demonstrates that the general
localization pattern ofRNA complexes is not perturbed by
the SDS method . This is further supported by the labeling
patterns obtained with antibodies specific for hnRNP pro-
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teins, snRNP proteins, and splicing factors using the SDS
method, all of which are similar to the labeling patterns seen
previously with these reagents using alternative in situ fixa-
tion and staining procedures (this work and other data not
shown) . We conclude that the SDS method described here
allows efficient and highly specific in situ detection ofRNA-
protein complexes in mammalian cells .
snRNRrich FociAre DistinctfromOther
snRNRcontaining Nucleoplasmic "Speckles"
Having established that each of the Ul, U2, U4/U6, and U5
snRNPs are present in all the nuclear structures that make
up the overall "speckled" labeling pattern (Figs . 1-3), we
next addressed whether the strongly staining foci were the
same as, or distinct from, the other nucleoplasmic
"speckles" In previous EM studies it was observed that
nuclear structures called interchromatin granules were
strongly labeled by anti-Sm antibodies (21, 61) . Based on
these observations it was proposed that clusters of inter-
4Figure 3. Competitive hybridization experiments on SDS-extracted cells . Each of the Ul (A), U2 (B), and U3 (C) snRNA probes was
hybridized in situ together with a 100-fold molar excess of non-biotinylated probe of different sequence, complementary to, respectively,
U3 (A and B) or U2 (C) snRNAs . Cells were double labeled with the U2-specific anti-B" antibody (D, E, and F) . In situ hybridization
with Ul (G), U2 (N), and U3 (I) snRNA probes in the presence of 100-fold molar excess of nonbiotinylated probe of identical sequence
abolishes nuclear staining but does not interfere with anti-B" antibody labeling (J, K, L) . Bar, 10 um .
chromatin granules are the "speckled" structures seen in the
light microscope. A mAb (3C5) has been described which
predominantly stains interchromatin granules (67, 68) . In-
terestingly, the3C5 monoclonal has been shown to recognize
a group of proteins on Western blots through a shared phos-
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phorylated epitope (66) . We therefore used this monoclonal
to compare its in situ labeling pattern with the U2 snRNP-
specific anti-B" antibody (Fig . 4, A-C) .
Double labeling with 3C5 and anti-B" shows that the foci,
which are brightly stained by the anti-B" antibody (Fig . 4 A,
5Figure 4 . snRNPrich foci are distinct from "speckles." HeLa cells extracted with Triton X-100were double labeled with the U2-specific
anti-B" (A) and 3C5 (B) antibodies . The overlay (C) shows that the foci stained by the anti-B" antibody (arrows) are not labeled by the
3C5 monoclonal, although the speckled structures do colocalize . Double labeling with SC35 (D) and 3C5 (E) mAbs shows that they
colocalize in "speckles" (F) . In the overlays (C-F) colocalization of labeling results in a change in color. Bar, 10 pm .
FigureS . saRNP-rich foci are coiled bodies . HeLa cells extracted withSDS were double labeled with the U2snRNAprobe (A) and anti-p80
coilin antibody (B) . The overlay shows that both probes label the same foci (C) . Double labeling on SDS-extracted cells with SC-35 (D)
and anti-p80 coilin (E) antibodies reveals no colocalization in the overlay (F) . Bar, 10 /Am .
arrows), do not colocalize with the 3C5 monoclonal (Fig . 4
C, arrows ; note green foci) . However, the additional "speck-
led" structures labeledby the anti-B" antibody do colocalize
with the 3C5 monoclonal (Fig . 4 C, orange "speckles . This
indicates that only these additional "speckles," and not the
foci, correspond to interchromatin granules . Another mAb,
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called SC-35 (23), which recognizes a non-snRNP splicing
factor, also stains the speckled structures but not the bright
foci (16) . A double-labeling experiment with mAbs SC-35
and 3C5 shows that their staining patterns colocalize in
"speckles" (Fig . 4, D-F), indicating that the anti-SC-35 anti-
body is also staining interchromatin granules. This agrees
6with the recent data of Spector et al. (62) which show at the
EM level that interchromatin granules and perichromatin
fibrils are stained by the anti-SC-35 antibody.
We conclude from these data: (a) the brightly staining foci
are distinct structures in the overall "speckled" pattern; (b)
the foci differ from the interchromatin granules stained by
the 3C5 and anti-SC-35 mAbs; and (c) in addition to being
in foci, Ul, U2, U4/U6, and U5 snRNPs are each also pres-
ent in interchromatin granules.
ThesnRNRrich Foci Correspond to CoiledBodies
In addition to interchromatin granules, Fakan et al. (21),
reported that at the EM levelperichromatin fibrils and coiled
bodies were also nuclear structures preferentially stained by
anti-Sm antibodies. Recently, a new class of autoimmune an-
tibodies has been characterized which specifically label
coiled bodies (50, 51). These antibodies recognize a protein
of 80 kD, termed p80 coilin. Antibodies affinity purified
using the COON-terminal fragment of p80 coilin, expressed
from a cDNA clone, also specifically label coiled bodies (1).
Coiled bodies are also stained specifically by rabbit antibod-
ies raised against recombinant p80 coilin. We have therefore
used both coilin-specific human sera and antibodies raised
against recombinant p80 coilin to determine whether the
snRNP-rich foci correspond to coiled bodies (Fig. 5) .
A perfect colocalization was observed between p80 coilin
staining and the foci detected using the U2-specific antisense
probe (Fig. 5, A-C, yellow structures in C) . All oligonu-
cleotide and antibody probes which label the foci precisely
colocalize with anti-p80 coilin staining in double-labeling
experiments (this work and other data not shown). As an ad-
ditional control, double labeling was done with anti-SC-35
and anti-p80 coilin antibodies (Fig. 5, D-F) . As expected
from our previous studies (16), no overlap or colocalization
was observed.
We conclude that the snRNP-rich nuclear foci correspond
to coiled bodies. These data also indicate, in agreement with
the findings of Raska et al. (51), that anti-p80 coilin antibod-
ies do not label interchromatin granules and do not colocal-
ize with the SC-35 antigen.
Association ofsnRNPs with Coiled Bodies
IsDisruptedbyHeatShock
The heat shock response is known to cause a major change
in transcriptional activity in vivo, resulting in most RNA
polymerase II transcripts being inhibited with a concomitant
induction of specific "heat shock" genes (for reviews see
references 19, 39). There is also evidence that pre-mRNA
splicing can be inhibited by heat shock both in vivo and in
vitro (12, 13, and 73). It has also been shown that heat shock
affects snRNP-snRNP interactions and in particular disrupts
the U4/U5/U6 triple snRNP (12) . We have therefore ana-
lyzed how the in situ distribution of each snRNP species is
affected during heat shock and subsequentrecovery (Fig. 6) .
HeLa cells were heat shocked by a temperature shift from
37° to 45°C for 15 min. In the majority of cells a dramatic
change was observed in the nuclear distribution of snRNNs.
Both antibody and antisense probes show a widespread,
rather diffuse nucleoplasmic snRNP staining after heat
shock, although nucleolar exclusion is maintained (Fig. 6,
A-C, and other data not shown). We note that colocalization
of antibody and antisense probes is still observed after heat
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shock, indicating that the protein and snRNA components
have not been dissociated. For both Ul and U2 snRNNs, dou-
ble labeling with antisense probes and the anti-p80 coilin an-
tibody also shows that they no longer concentrate in coiled
bodies (Fig. 6, compare A and D and B and E) . Similar
results are obtained with probes for the other splicing
snRNNs (data not shown). Foci ofp80 coilin staining are still
observed after heat shock (Fig. 6, D and E), although some
cells show a partial disruption of the usual regular appear-
ance of coiled bodies seen in non-heat-shocked cells. In
agreement with the recent findings of Spector et al. (62), we
observe that the association of snRNNs with "speckled"
structures is also disrupted by heat shock. However, U3
snRNP is still detected exclusively in nucleoli after a similar
heat shock (Fig. 6 F) .
In cellsmaintained at 37°C, or allowed to recover at 37°C
for 15 min after heat shock, snRNNs are again observed to
concentrate in coiled bodies (Fig. 6, G-Iand J-L) . Note that
after recovery from heat shock the staining pattern is re-
stored to that seen in non-heat shocked cells, including the
typical bright labeling of foci and additional nucleoplasmic
"speckles" (Fig. 6 I).
We conclude: (a) heat shock affects the association of each
of the spliceosomal snRNPs with coiled bodies and (b) the
spliceosomal snRNNs are apparently no longer localized to
specific nucleoplasmic structures during the heat shock re-
sponse but nevertheless remain in the nucleoplasm and do
not enter the cytoplasm or nucleoli.
snRNPs DoNotColocalize withp80 Coilin when
T}anscription IsInhibitedbyActinomycin D
Ifthe presence of snRNNs in coiled bodies is connected with
the processing or metabolism ofpre-mRNA then this associ-
ation might be dependent upon the production of nascent
transcripts in the nucleus. Experiments were therefore done
to assess how the nuclear snRNP distribution is affected by
blocking transcription with either actinomycin D or a-aman-
itin (see Figs. 7-10) .
We have previously shown that treating cells with ac-
tinomycin D, which inhibits all nuclear transcription, results
in an astonishing change in the Ul snRNP labeling pattern
(15, 16). In actinomycin-treated cells both Ul snRNP and the
splicing factor U2AF, but not the other spliceosomal
snRNNs, hnRNP proteins or the splicing factor SC-35, be-
come concentrated around remnants ofnucleoli . In contrast,
the U2, U4/U6, and U5 snRNNs, and the splicing factor
SC-35, remain colocalized in "speckled" nucleoplasmic
structures (16; and other data not shown). These earlier
studies could not however distinguish whether any of these
"speckled" staining structures observed after actinomycin D
treatment correspond to foci/coiled bodies.
Double-labeling experiments were carried out with both
an antisense probe and mAb specific for U2 snRNP and the
anti-p80 coilin antibody, before and after actinomycin D
treatment (Fig. 7, compare A and D and B and E) . This
shows that U2 snRNP no longer colocalizes with p80 coilin
after cells are exposed to actinomycin D. Similar results are
obtained with probes specific for U4/U6 or U5 snRNNs
(data not shown). Each of these snRNPs still show concen-
trated staining in "speckled" structures however and do not
appear widely dispersed in the nucleoplasm as during the
heat-shock response. The anti-p80 coilin staining is alsoFigure 6 . Heat shock affects the distribution ofsnRNPs .HeLa cells were heat-shocked at 45'C for 15 min before fixation and SDS extraction
(A-F) . Antisense probes to Ul (A), U2 (B), and U6 (C) snRNAs show a widespread uniform labeling of the nucleoplasm, excluding
nucleoli . The pattern of p80 coilin staining in the same cells remains unaffected (D andE) . The U3 snRNA in heat-shocked cells is still
detected exclusively in the nucleolus (F). Control cells incubated at 37°C and double labeled with Ul (G) or U2 (H) snRNA probes and
anti-p80 coilin antibody (JandK) show the characteristic snRNP-rich foci (arrows) . Note that foci labeled with theUlsnRNA probe appear
less prominentdue to the intense widespread staining of the nucleoplasm (G) . When cells are allowed to recover at 37°C for 15 min after
heat shock, the U2snRNA (1, arrows) is again concentrated in foci which colocalize with p80 coilin (L) . Bar, 10 wm .
changed after actinomycin D treatment (50), and appears
clustered around nucleolar remnants in a distinct, though
possibly overlapping, pattern to that seen forU1 snRNP and
U2AF (Fig . 7, compare C and F; see also reference 16).
We conclude that spliceosomal snRNPs no longer concen-
trate in coiled bodies after actinomycin D treatment . Al-
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though we had previously observed nucleoplasmic "foci,
containing U2, U4/U6, and U5 snRNPs, whichremained af-
ter actinomycin D treatment (15), it is now clear from the
double labeling with anti-p80 coilin antibodies that these
structures are differentfrom thebrightly staining foci (coiled
bodies) seen in untreated cells . These snRNP-containing
8Figure 7 . Actinomycin D disrupts coiled bodies . HeLa cells extracted with Triton X-100 and labeled with U2-specific anti-B" antibody
(A) show foci (arrows) which perfectly colocalize with anti-p80 coilin (B) . After 1-h treatment with actinomycin D (5 pg/ml) the U2 an-
tisense probe (B) shows an altered staining pattern which no longer colocalize with p80 coilin (E) . Double labeling ofactinonrycin D-treated
cells with the Ul-specific anti-70K mAb (C) and anti-p80 coilin antibody (F) shows that p80 coilin clusters around the nucleolus in a
nonidentical pattern to that seen for U1snRNP Bar, 10 l.m .
nucleoplasmic "speckled structures also label with the anti-
SC-35 and 3C5 mAbs and therefore likely correspond to, or
are derived from, the "speckles" present in untreated cells .
snRNPs Concentrate in "Speckles"butnotCoiled
Bodies afteraAmanitin Treatment
Actinomycin D inhibits rRNA as well as mRNA and tRNA
synthesis and causes significant changes in nuclear morphol-
ogy, including nucleolar breakdown . In contrast, o-amanitin
selectively inhibits transcription by RNA polymerase II and,
at higher concentrations, RNA polymerase III, but does not
block rRNA synthesis . We therefore tested whether treat-
ment ofHeLa cells with a-amanitin also affected the in situ
distribution of snRNPs between the different nuclear com-
partments (see Figs . 8-10) .
HeLa cells were incubated for 5 h in culture medium con-
taining a-amanitin as previously described (40) . A major
change in the pattern of U2 snRNP staining was observed
(Fig. 8, compare A and B) . Both the U2-specific antisense
probe and mAb (anti-B") intensely label nucleoplasmic
"speckles" after a-amanitin treatment (Fig . 8, B, C, and F) .
Note that a perfect colocalization oftheU2 antisense and an-
tibody probes is still seen after a-amanitin treatment (Fig.
8, C and F) . However, neither probe now shows U2 colocal-
ized with p80 coilin (Fig . 8, compare A and D with B and
E, and data not shown) . p80 coilin staining was also affected
by a-amanitin ; in most cases foci were disrupted and many
cells showed "caps" of p80 coilin clustered around nucleoli
(Fig . 8, compareD and E) .
After a-amanitin treatment the mAbs anti-B" and 3C5
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colocalize in the large, bright "speckles" (Fig . 8, compare G
and J withHandK) . A monoclonal anti-m3G-Cap antibody
also colocalizes in the large "speckles" with 3C5 on a-aman-
itin-treated cells (Fig . 8, compare I and L), as does SC-35
(data not shown) . The same structures are labeled with the
3C5 antibody and probes specific for Ul (Fig . 9, compare
A and D) andU4/U6 and U5 snRNAs (data not shown) . Un-
like the other snRNPs, Ul is additionally detected in
perinucleolar structures after a-amanitin treatment (Fig . 9
A) . These data again demonstrate a difference between Ul
and the other spliceosomal snRNPs. a-amanitin does not
produce any major changes in the pattern ofhnRNP staining
and does not cause hnRNPs to colocalize in the "speckles"
stained by the 3C5 mAb (Fig . 9, compareB andE and Cand
F) . Note that concentrated regions ofhnRNP L staining per-
sist after a-amanitin treatment, but do not obviously colocal-
ize with any of the structures labeled by 3C5 (Fig . 9, com-
pare C and F) .
The effect of a-amanitin has also been studied by directly
injecting it into the nuclei ofHeLa cells and then comparing
the snRNP distribution in both injected and uninjected cells .
In all injected cells, the anti-U2 staining was concentrated
in large, bright, nucleoplasmic "speckles" (Fig . 10 A) . These
"speckles" colocalized with the 3C5 monoclonal (data not
shown) . Again, after a-amanitin, colocalization was no
longer observed between anti-U2 snRNP and anti-p80 coilin
staining (Fig. 10, compare A andB) . In a few cells, foci of
p80 coilin staining could still be seen, but snRNPs were not
concentrated in these structures (Fig . 10, arrows) . Interest-
ingly, these residual foci were often observed adjacent to en-
larged speckles (Fig . 10 A, arrows and arrowheads) . An es-
9Figure8 . snRNPs concentrate in "speckles" after amanitin treatment . In control experiments HeLa cellswere extracted with Triton X-100
and double labeled with the U2-specific anti-B" (A) and anti-p80 coilin (D) antibodies . U2snRNP is concentrated in coiled bodies (arrows)
and additionally is present in nucleoplasmic "speckles." After 5-h exposure to a-amanitin (50 FAg/ml) the anti-B" staining concentrates in
large, bright speckles (B)whichare distinct from the cap-like structures associated with the nucleolusseen with the anti-p80 coilin antibody
(E) . Double labeling ofa-amanitin-treated cells with anti-B" antibody (C)andU2snRNA antisenseprobe(F) show perfect colocalization .
In control, Triton-extracted cells, double labeling with anti-B" (G)and3C5(J) antibodies shows that only the "speckles" andnot the bright
foci (arrows) colocalize . After amanitin treatment there is a perfect colocalization of anti-B" (H) and 3C5 (K) staining . Colocalization
is also observed in amanitin-treated cells double labeled with anti-m3G cap (I) and 3C5 (L) antibodies . Bar, 10 lm .
sentially identical response was obtained after injection of
a-amanitin at concentrations ranging from 10-100 leg/ml .
No such changes in snRNP labeling were seen in any unin-
jected cells or in the cells injected with solvent not contain-
ing a-amanitin (data not shown) .
In summary, these data show that after cells are exposed
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to a-amanitin the pattern of snRNP labeling changes such
that spliceosomal snRNPs no longer concentrate in foci and
no longer colocalize with p80 coilin . Instead, each of theUl,
U2, U4/U6, and U5 snRNPs concentrate in large, brightly
staining "speckles." These structures likely correspond to en-
larged clusters of interchromatin granules . The widespread
10Figure 9 a-amanitin differentially affects snRNP and hnRNP staining . a-Amanitin-treated cells were Triton-extracted and double labeled
with mAbs specific for UlsnRNP 70K protein (A), hnRNP C (B), or hnRNP L (C) andmonoclonal 3C5 (D, E, and F) . The Ul snRNP
is detected both in "speckles" (A, arrows) which colocalize with 3C5 (D, arrows) and in perinucleolar structures (A, arrowheads) which
are recognized more weakly by the3C5 antibody (D, arrowheads) . Anti-hnRNP C and L antibodies show widespread nucleoplasmic stain-
ing . They do not concentrate in speckles (B and C) and do not colocalize with the3C5 monoclonal (E andF) . Note that the concentrated
regions ofhnRNPLstaining persist after a-amanitin treatment (C, arrowhead) and show no apparent relation to the 3C5-stained "speckles"
(F) . Bar, 10 um .
Figure 10 . Microinjection of a-amanitin into HeLa cell nuclei . Cells were microinjected with a-amanitin (10 jig/nil) and incubated for
1 hbefore Triton extraction and fixation . In injected cells the anti-B" staining concentrates in large, bright "speckles" (A) . Double labeling
with anti-p80 coilin antibody (B) shows no colocalization in the large "speckles." In some cells foci of p80 coilin staining are observed
(lower cell) while in others the staining pattern appears fragmented (upper cell) . Note that anti-B" and anti-p80 coilin antibodies occasion-
ally colocalize in foci adjacent to enlarged speckles (arrows) . Bar, 10 pm .
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1 1nucleoplasmic staining outside of "speckles" and coiled bod-
ies which is normally seen in untreated cells is also greatly
reduced or eliminated aftera-amanitintreatment. This effect
is particularly striking for Ul snRNP, which shows the
highest level of widespread nucleoplasmic staining in un-
treated cells.
Discussion
In this study, the snRNP-rich nuclear foci which we had re-
cently identified in mammalian nuclei are shown to be coiled
bodies. In addition, we have established in situ labeling con-
ditions which demonstrate that each of the Ul, U2, U4/U6,
and U5 snRNNs are also present throughoutthe nucleoplasm
and are enriched in clusters of interchromatin granules. One
conclusion from these studies therefore is that the punctate
or "speckled" pattern seen by immunofluorescence in cells
stained with anti-Sm or anti-m3G-Cap antibodies is not ho-
mogeneous, but rather includes at least two separate types
of nuclear structures, i.e., coiled bodies and interchromatin
granules. At the EM level, coiled bodies and interchromatin
granules are morphologically distinct (42) . It is now appar-
ent that they are also functionally distinct compartments, as
snRNP association with coiled bodies and interchromatin
granules is differentially affected by both actinomycin D and
a-amanitin (Figs. 7-10) . From our previous analyses the
snRNPs in coiled bodies also appear more accessible to an-
tisense probes, both in situ (15; and this study) and in vivo
(16), than the same snRNP species present in interchromatin
granules. These observations suggest that the snRNPs pres-
ent in coiled bodies and interchromatin granules might be in-
volved in different metabolic activities.
Previously, using antibodies specific for Sm proteins or
m3G-Cap structures, it could not be distinguished whether
all classes of snRNP, or only a sub-set, were present at any
given nuclear location. This is an important point for con-
sidering possible sites in the nucleus where pre-mRNA
splicing can occur, as each of these snRNPs is required in
vitro for splicing and spliceosome assembly. The present
study provides a clear demonstration that each species of
spliceosomal snRNP is present in multiple nucleoplasmic lo-
cations. As a perfect colocalization is observed for the stain-
ing patterns of antisense probes and cognate mAbs specific
for both Ul and U2 snRNPs, we can also now be confident
that mature snRNP particles are being detected and not na-
scent snRNAs or pools ofunassembled snRNP proteins. Un-
fortunately, in the case ofmammalian U4/U6or U5 snRNPs,
no specific antibodies are currently available to use in con-
junction with the antisense probes for double-labeling ex-
periments. From our studies with the antisense probes alone
however it appears that U4/U6 and U5 have a similar in situ
distribution to U2 snRNP In contrast, Ul snRNP shows an
interesting quantitative difference in its distribution. Here,
and in our previous in situ and in vivo studies (15, 16), we
observe a larger fraction of Ul snRNP widely distributed
throughout the nucleoplasm rather than concentrated in
coiled bodies or "speckles." This distribution resembles that
seen for the non-snRNP splicing factor U2AF and we have
presented evidence that Ul and U2AF may exist in some
form of common complex in vivo (16). Both actinomycin D
and a-amanitin also affect Ul differently from U2, U4/U6,
and U5. Interestingly, recent studies of snRNP distribution
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in Xenopus oocytes also point to a difference in the organiza-
tion of Ul relative to the other spliceosomal snRNPs
(reviewed in reference 24). In oocytes, Ul is detected both
in particles containing all species of snRNPs ("B snurpo-
somes") and in distinct particles containingjust Ul ("A snur-
posomes"). Data from in vitro splicing studies may point to
a possible functional difference between Ul and the other
snRNPs; e.g., Ul alone bindsto 5'splice sites, is able to bind
pre-mRNA in the absence of ATP, kinetically is the first
snRNP to assemble on splicing substrates and also appears
to bind less stably to the spliceosome than the other snRNP
species (reviewed in references 38, 53). It seems plausible
therefore that the difference we have observed in mammalian
cellsbetween Ul snRNP distribution and that of U2, U4/U6,
and U5 reflects a genuine difference in its functional role in
vivo.
The data presented here show that snRNPs are no longer
found concentrated in coiled bodies when cells are treated
with the transcription inhibitors a-amanitin or actinomycin
D, or when cells are heat shocked (Figs. 7-10). The associa-
tion of snRNPs with coiled bodies may therefore depend
directly on the presence of newly synthesized pre-mRNA.
These observations argue in favor of coiled bodies playing
an active role in the metabolism of nuclear pre-mRNA. This
is consistent with our previous proposal that the snRNP-rich
nuclear foci (coiled bodies), represent nuclear organelles or
compartments in which a specific part of the pre-mRNA
maturationpathway takes place (16). An important corollary
of these data is that changes in metabolic activity within a
cell can cause changes in the relative concentrations of
snRNP present in different nuclear structures. It is therefore
possible that different patterns of snRNP distribution may be
found in other cell types which differ in their metabolic ac-
tivity from the HeLa cells used in this study. In this regard
it will be interesting to compare how snRNP distributions
are affected when cells in culture are induced to differentiate
and undergo major changes in their metabolism and pattern
of gene expression.
The coiled body is a nuclear structure that was originally
seen in 1903 by Ramon y Cajal, who called it the "accessory
body" (49) . Subsequent ultrastructural studies identified nu-
clear "accessory bodies" (29) and "coiled bodies" (42) in the
electron microscope and these structures were later con-
firmed as being the accessory bodies described by Ramon y
Cajal (35, 56). Coiled bodies are typically described at the
ultrastructural level as oval to spherical inclusions, ranging
in size from 0.3-0.9 tim and giving the appearance of bun-
dles of "knotted threads." They also appear to be highly con-
served in evolutionary terms, showing a similar appearance
in eukaryotes as diverged as plants and mammals (43, 57) .
While an extensive literature exists describing the appear-
ance and occurrenceof coiled bodies, few functional studies
have been carried out to address their biological role. As
coiled bodies are often observed close to nucleoli, particu-
larly in neuronal cells, it has frequently been suggested that
they could play a role in nucleolar function (29, 42, 50, 56,
and 57). In contrast, Schultz (57) speculated that coiled bod-
ies may correspond to assemblies of spliceosomes. Fakan et
al. (21) observed at the EM level that coiled bodies were
among the nuclear structures which were preferentially la-
beled by anti-Sm and anti-hnRNP antibodies. This is consis-
tent with them being involved in pre-mRNA metabolism.
12Furthermore, studies on plant coiled bodies have shown that
they are sites of acid phosphatase activity, which is also sug-
gestive of an RNA processing activity (43).
Although the data in this study strongly support the view
that coiled bodies are involved in pre-mRNA metabolism,
they do not prove that coiled bodies are actual sites of pre-
mRNA spicing. The observed concentration of snRNPs and
the splicing factor U2AF in coiled bodies, and the apparent
dependence of this association on the production of nascent
transcripts, is also consistent with them having a role in pre-
mRNA metabolism before or after splicing has taken place.
For example, coiled bodies couldrepresent organelles where
snRNPs are pre-assembled, together with other splicing fac-
tors. Alternatively, they could be sites where introns are
debranched and/or degraded after splicing, where snRNPs
are recycled from post-splicing complexes or where intron
and mRNA splicing products are sorted out as part of a nu-
clear export pathway. We note that if coiled bodies play a role
in some post-splicing event, then any splicing factors which
do not remain bound to spliceosomes after exon ligation is
completed would not accumulate there. This is a possible ex-
planation why the splicing factor SC-35 is not detected in
coiled bodies (16). If coiled bodies do represent actual sites
of pre-mRNA splicing, it is also conceivable that they are
specialized structures dedicated to the processing of a
specific sub-set ofpre-mRNAs. In a recent study Wang et al.
(71) showed that when in vitro synthesized pre-mRNAs were
injected into mammalian cells they became localized in
punctate nuclear structures, including those stained by anti-
Sm and anti-SC-35 antibodies. It will be interesting now to
determine whether any of these structures in which exoge-
nous pre-mRNAs concentrate correspond to coiled bodies.
Experiments are currently in progress to purify coiled
bodies from mammalian cells and characterize biochemi-
cally their composition. Hopefully such studies will lead to
a clearer understanding of the in vivo role of coiled bodies
and their significance for nuclear pre-mRNA metabolism.
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